TrialLung2021

Redefining the Risk of Surgery for Clinical Stage IIIA (N2) Non-Small Cell Lung Cancer: A Pooled Analysis of the STS GTSD and ESTS Registry.

Andrew T Arndt et al.PubMed ↗Publisher ↗

No numbers read from the abstract.